Last reviewed · How we verify
Dienogest 2mg
At a glance
| Generic name | Dienogest 2mg |
|---|---|
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma (PHASE2, PHASE3)
- Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery (PHASE3)
- Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis (PHASE4)
- The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation (PHASE4)
- Dienogest in Perimenopausal Women With Adenomyosis
- Dienogest Versus GnRH-a Pre-treatment in Women With Endometriosis Undergoing IVF (NA)
- Goserline Acetate VS Dienogest in Endometriosi (PHASE4)
- Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dienogest 2mg CI brief — competitive landscape report
- Dienogest 2mg updates RSS · CI watch RSS
- Ain Shams University portfolio CI